scholarly article | Q13442814 |
P50 | author | James L Wynn | Q47503963 |
Lyle L Moldawer | Q92147747 | ||
Philip Efron | Q114427345 | ||
P2093 | author name string | Mark A Atkinson | |
Westley H Reeves | |||
Philip O Scumpia | |||
Kerri A O'Malley | |||
Matthew J Delano | |||
Priscilla F McAuliffe | |||
Tolga Barker | |||
Todd Brusko | |||
Ricardo Ungaro | |||
Kindra M Kelly | |||
Michael J Clare Salzler | |||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | sepsis | Q183134 |
P304 | page(s) | 7943-7949 | |
P577 | publication date | 2006-12-01 | |
P1433 | published in | Journal of Immunology | Q3521441 |
P1476 | title | Increased natural CD4+CD25+ regulatory T cells and their suppressor activity do not contribute to mortality in murine polymicrobial sepsis | |
P478 | volume | 177 |
Q35988687 | A Detailed Characterization of the Dysfunctional Immunity and Abnormal Myelopoiesis Induced by Severe Shock and Trauma in the Aged |
Q36633756 | A prospective analysis of lymphocyte phenotype and function over the course of acute sepsis |
Q36964169 | Adenosine promotes Foxp3 expression in Treg cells in sepsis model by activating JNK/AP-1 pathway |
Q34666178 | Adoptive transfer of bone marrow-derived dendritic cells decreases inhibitory and regulatory T-cell differentiation and improves survival in murine polymicrobial sepsis |
Q37448845 | Aged mice are unable to mount an effective myeloid response to sepsis |
Q49751937 | Autophagy: A Potential Therapeutic Target for Reversing Sepsis-Induced Immunosuppression |
Q35144572 | B cells enhance early innate immune responses during bacterial sepsis |
Q34270607 | Baicalin improves survival in a murine model of polymicrobial sepsis via suppressing inflammatory response and lymphocyte apoptosis |
Q35703434 | CCR4 Controls the Suppressive Effects of Regulatory T Cells on Early and Late Events during Severe Sepsis |
Q98177684 | CD4 T Cell Responses and the Sepsis-Induced Immunoparalysis State |
Q37233187 | CD4+ lymphocytes control gut epithelial apoptosis and mediate survival in sepsis |
Q34680364 | Cecal ligation and puncture. |
Q35091478 | Cholinergic regulatory lymphocytes re-establish neuromodulation of innate immune responses in sepsis |
Q51545819 | Cold-inducible RNA-binding protein activates splenic T cells during sepsis in a TLR4-dependent manner. |
Q35328903 | Critical role for CXC ligand 10/CXC receptor 3 signaling in the murine neonatal response to sepsis. |
Q36259440 | Differential alterations of tissue T-cell subsets after sepsis. |
Q37123856 | Differential lymphopenia-induced homeostatic proliferation for CD4+ and CD8+ T cells following septic injury |
Q85122089 | Effects of Hypertonic Saline on CD4+CD25+Foxp3+ Regulatory T Cells After Hemorrhagic Shock in Relation to iNOS and Cytokines |
Q34974970 | Epigenetic regulation of immune cell functions during post-septic immunosuppression |
Q37484450 | Flagellin treatment prevents increased susceptibility to systemic bacterial infection after injury by inhibiting anti-inflammatory IL-10+ IL-12- neutrophil polarization |
Q27317316 | Foxp3+ regulatory T cells are required for recovery from severe sepsis |
Q35013590 | Full activation of CD4+ T cells early during sepsis requires specific antigen |
Q36054573 | Genome-level longitudinal expression of signaling pathways and gene networks in pediatric septic shock |
Q34612795 | Heterotrimeric Gα(i) proteins are regulated by lipopolysaccharide and are anti-inflammatory in endotoxemia and polymicrobial sepsis |
Q54269422 | IL-7 treatment augments and prolongs sepsis-induced expansion of IL-10-producing B lymphocytes and myeloid-derived suppressor cells. |
Q57099347 | Identifying Therapeutic Targets for Sepsis Research: A Characterization Study of the Inflammatory Players in the Cecal Ligation and Puncture Model |
Q38697751 | In Search of a Cure for Sepsis: Taming the Monster in Critical Care Medicine. |
Q34599210 | Increased circulating regulatory T cells (CD4(+)CD25 (+)CD127 (-)) contribute to lymphocyte anergy in septic shock patients |
Q34302328 | Increased percentages of T helper cells producing IL-17 and monocytes expressing markers of alternative activation in patients with sepsis |
Q36793578 | Innate lymphocyte subsets and their immunoregulatory roles in burn injury and sepsis |
Q42851616 | Mifepristone (RU486) restores humoral and T cell-mediated immune response in endotoxin immunosuppressed mice. |
Q34585151 | Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony |
Q36229458 | MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis |
Q30419805 | Neutrophil mobilization from the bone marrow during polymicrobial sepsis is dependent on CXCL12 signaling |
Q38116494 | Pathways mediating resolution of inflammation: when enough is too much |
Q36995660 | Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care |
Q50133355 | Polymicrobial sepsis and non-specific immunization induce adaptive immunosuppression to a similar degree. |
Q34602396 | Potential role of myeloid cell/eosinophil-derived IL-17 in LPS-induced endotoxin shock |
Q42156879 | Probiotics improve survival of septic rats by suppressing conditioned pathogens in ascites |
Q34499856 | Quantification of regulatory T cells in septic patients by real-time PCR-based methylation assay and flow cytometry |
Q34723343 | Regulatory T cells are protective in systemic inflammation response syndrome induced by zymosan in mice |
Q86124554 | Regulatory T cells in the blood: a new marker of surgical stress |
Q40852334 | Relevance of Foxp3⁺ regulatory T cells for early and late phases of murine sepsis |
Q38890353 | Role of cellular events in the pathophysiology of sepsis |
Q36331149 | STAT3-mediated IL-17 production by postseptic T cells exacerbates viral immunopathology of the lung |
Q59136322 | Sepsis and Nosocomial Infection: Patient Characteristics, Mechanisms, and Modulation |
Q37166367 | Sepsis induces early alterations in innate immunity that impact mortality to secondary infection |
Q49790787 | Sepsis-Induced T Cell Immunoparalysis: The Ins and Outs of Impaired T Cell Immunity. |
Q36430684 | Sepsis-induced immune dysfunction: can immune therapies reduce mortality? |
Q34217664 | Systemic treatment with CpG-B after sublethal rickettsial infection induces mouse death through indoleamine 2,3-dioxygenase (IDO). |
Q38991057 | The immune system's role in sepsis progression, resolution, and long-term outcome |
Q27022093 | The immunopathology of sepsis: pathogen recognition, systemic inflammation, the compensatory anti-inflammatory response, and regulatory T cells |
Q41128947 | The kinetics of T regulatory cells in shock: beyond sepsis. |
Q33896697 | The post sepsis-induced expansion and enhanced function of regulatory T cells create an environment to potentiate tumor growth |
Q33873468 | The relationship between CD4+CD25+CD127- regulatory T cells and inflammatory response and outcome during shock states |
Q35205781 | The role of regulatory T cells in immune dysfunction during sepsis |
Q27004368 | The role of regulatory T cells in the pathogenesis of sepsis and its clinical implication |
Q26860731 | Trauma equals danger--damage control by the immune system |
Q34581804 | Treatment with GITR agonistic antibody corrects adaptive immune dysfunction in sepsis |
Q33656087 | Type I interferon signaling in hematopoietic cells is required for survival in mouse polymicrobial sepsis by regulating CXCL10. |
Search more.